clofibrate has been researched along with Lipodystrophy in 1 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Lipodystrophy: A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunnigan, MG | 1 |
| Cochrane, MA | 1 |
| Kelly, A | 1 |
| Scott, JW | 1 |
1 other study available for clofibrate and Lipodystrophy
| Article | Year |
|---|---|
Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
Topics: Adult; Chlorpropamide; Cholesterol; Clofibrate; Diabetes Mellitus; Dietary Carbohydrates; Female; Ge | 1974 |